Loading news...
Vaso (OTCMKTS:VASO - Get Free Report) and 908 Devices (NASDAQ: MASS - Get Free Report) are both small-cap medical companies, but which is the better business? We will compare the two companies based on the strength of their dividends, risk, institutional ownership, profitability, valuation, earnings and analyst recommendations. Profitability This table compares Vaso and 908 Devices'
908 Devices (MASS) was a big mover last session on higher-than-average trading volume. The latest trend in earnings estimate revisions might not help the stock continue moving higher in the near term.
BURLINGTON, Mass.--(BUSINESS WIRE)--908 Devices Inc. (Nasdaq: MASS), a core small-cap growth company focused on purpose-built handheld chemical analysis tools for vital health, safety and defense tech applications, today announced preliminary unaudited financial results for the quarter and full year ended December 31, 2025. Preliminary unaudited revenue for the fourth quarter of 2025 is approximately $17.2 million, compared to $14.3 million in the fourth quarter of 2024, reflecting reported gro.
Vancouver, British Columbia--(Newsfile Corp. - January 15, 2026) - Masivo Silver Corp. (TSXV: MASS) (OTC Pink: GNYPF) ("Masivo" or the "Company") reports that ongoing field operations at its newly optioned Cerro Colorado Project in Sonora, Mexico, will significantly ramp up with field crews, drill crews and equipment mobilizing to the project preparation for its 1500 meters Phase I drill program. With environmental approvals in place and private property access agreement, current activities include rehabilitation of access routes, construction of drill pads, and site preparation required to support drilling.
Vancouver, British Columbia--(Newsfile Corp. - December 22, 2025) - Masivo Silver Corp. (TSXV: MASS) (OTC Pink: GNYPF) ("Masivo" or the "Company") is pleased to provide an update on ongoing exploration and permitting activities at its Cerro Colorado Project, located in the State of Sonora, Mexico. Permitting Progress Masivo reports that it has submitted the required environmental permit applications to SEMARNAT (Secretaría de Medio Ambiente y Recursos Naturales) in support of its proposed exploration activities at the Cerro Colorado Project.
908 Devices Inc. ( MASS ) Q3 2025 Earnings Call November 10, 2025 8:30 AM EST Company Participants Barbara Russo - VP of Marketing & Corporate Communications Kevin Knopp - Co-Founder, CEO, President & Director Joseph Griffith - CFO & Treasurer Conference Call Participants Puneet Souda - Leerink Partners LLC, Research Division Matthew Larew - William Blair & Company L.L.C., Research Division Brendan Smith - TD Cowen, Research Division Daniel Arias - Stifel, Nicolaus & Company, Incorporated, Research Division Presentation Operator Ladies and gentlemen, thank you for joining us, and welcome to the 908 Devices Third Quarter 2025 Financial Results Conference Call.
908 Devices Inc. (MASS) came out with a quarterly loss of $0.15 per share versus the Zacks Consensus Estimate of a loss of $0.13. This compares to a loss of $0.23 per share a year ago.
BOSTON--(BUSINESS WIRE)--908 Devices Inc. (Nasdaq: MASS), a core small-cap growth company focused on purpose-built handheld chemical analysis tools for vital health, safety and defense tech applications, today reported financial results for the quarter ended September 30, 2025. “We are pleased with our year-to-date progress as we continue to build a more predictable and profitable business and bring our 908 Devices 2.0 vision to life,” said Kevin J. Knopp, CEO and Co-founder. “Revenue for the f.
908 Devices (MASS) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
BOSTON--(BUSINESS WIRE)--908 Devices Inc. (Nasdaq: MASS), a core small-cap growth company focused on purpose-built handheld chemical analysis tools for vital health, safety and defense tech applications, today announced it will participate in the following investor conferences. Stifel Healthcare Conference, New York, NY Fireside chat on Wednesday, November 12 at 8:40 a.m. Eastern Time 27th Annual Stephens Investment Conference, Nashville, TN Fireside chat on Thursday, November 20 at 10 a.m. Cen.
BOSTON--(BUSINESS WIRE)-- #CoastGuard--908 Devices Inc. (Nasdaq: MASS), a pioneer of purpose-built handheld devices for chemical analysis, announces that the United States Coast Guard purchased 23 of the company's MX908 devices for narcotics interdiction efforts and hazardous threat detection, helping to safeguard ports, waterways and coastal communities. With this purchase, the Coast Guard is now fielding more than 35 MX908 devices across the maritime environment. Within the Coast Guard highly trained units.
BOSTON--(BUSINESS WIRE)--908 Devices Inc. (Nasdaq: MASS), a core small-cap growth company focused on purpose-built handheld chemical analysis tools for vital health, safety and defense tech applications, today announced it will report financial results for the third quarter 2025 before market open on Monday, November 10, 2025. Company management will webcast a corresponding conference call beginning at 8:30 a.m. Eastern Time / 5:30 a.m. Pacific Time. Live audio of the webcast will be available.
BOSTON--(BUSINESS WIRE)--908 Devices Inc. (Nasdaq: MASS), a pioneer of purpose-built handheld devices for chemical analysis, announces that the United States Marine Corps CBRNE Installation and Protection Program purchased 17 of the company's XplorIR devices for the chemical identification and quantification of hazardous gases and vapors. The program's mission is to support federal firefighters, military police, post offices and security augmentation forces with CBRNE (Chemical, Biological, Rad.
908 Devices (MASS) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings estimate revisions for the stock doesn't suggest further strength down the road.
908 Devices (MASS) Q2 Revenue Jumps 14%
908 Devices Inc. (NASDAQ:MASS ) Q2 2025 Earnings Conference Call August 5, 2025 8:30 AM ET Company Participants Joseph H. Griffith - CFO & Treasurer Kevin J.
908 Devices Inc. (MASS) came out with a quarterly loss of $0.18 per share versus the Zacks Consensus Estimate of a loss of $0.16. This compares to a loss of $0.32 per share a year ago.
BOSTON--(BUSINESS WIRE)-- #VipIR--908 Devices Inc. (Nasdaq: MASS), a core small-cap growth company focused on purpose-built handheld chemical analysis tools for vital health, safety and defense tech applications, today reported financial results for the quarter ended June 30, 2025. “We executed with urgency and discipline in the second quarter, driving strong top-line growth while advancing key structural initiatives to strengthen our financial profile,” said Kevin J. Knopp, CEO and Co-founder. “We deli.
BOSTON--(BUSINESS WIRE)-- #CBRN--908 Devices Inc. (Nasdaq: MASS), a pioneer of purpose-built handheld devices for chemical analysis, announces that it has appointed Dr. Brandi Vann to serve on its Board of Directors. During more than 15 years at the U.S. Department of Defense (DoD), Dr. Vann held several leadership positions overseeing nuclear, chemical, and biological defense programs. The company also announces that Jeff George, a veteran biopharma leader, has stepped down from its Board of Directors.
BOSTON--(BUSINESS WIRE)--908 Devices Inc. (Nasdaq: MASS), a core small-cap growth company focused on purpose-built handheld chemical analysis tools for vital health, safety and defense tech applications, announced it will participate in the upcoming Canaccord Genuity 45th Annual Growth Conference. 908 Devices' management is scheduled to present on Wednesday, August 13 at 1 p.m. Eastern Time. Interested parties may access a live and archived webcast of the presentation on the “Investors” section.